Research Project History

PI / Project Leader	YOLES, ETI
Awardee Organization	IMMUNOBRAIN CHECKPOINT INC.
Funding Agency/Organization	NIA
Sub-Project Number	None

Updates

Project Number	FY	FY Funding Amount	Project Title
3R01AG071810-01S1	2022	$250000	First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)
5R01AG071810-02	2022	$2234624	First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)
1R01AG071810-01	2021	$1984624	First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)